Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effectiveness of Aripiprazole, Quetiapine, and Ziprasidone in First Episode Psychosis (PAFIP II)
NCT02526030Phase 4Completed
- Sponsor
- Fundación Marqués de Valdecilla
- Start
- Oct 2008
- Primary completion
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of aripiprazole, quetiapine, ziprasidone in schizophrenia, psychotic disorders, sponsored by Fundación Marqués de Valdecilla. Started Oct 2008; status: completed.
02
Drugs
aripiprazolequetiapineziprasidone
03
Conditions
schizophreniapsychotic disorders
Beyond the preview
Go deeper on NCT02526030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02526030.